1. Home
  2. TROW vs DXCM Comparison

TROW vs DXCM Comparison

Compare TROW & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TROW
  • DXCM
  • Stock Information
  • Founded
  • TROW 1937
  • DXCM 1999
  • Country
  • TROW United States
  • DXCM United States
  • Employees
  • TROW N/A
  • DXCM N/A
  • Industry
  • TROW Investment Bankers/Brokers/Service
  • DXCM Medical/Dental Instruments
  • Sector
  • TROW Finance
  • DXCM Health Care
  • Exchange
  • TROW Nasdaq
  • DXCM Nasdaq
  • Market Cap
  • TROW 19.7B
  • DXCM 34.1B
  • IPO Year
  • TROW N/A
  • DXCM 2005
  • Fundamental
  • Price
  • TROW $100.15
  • DXCM $83.95
  • Analyst Decision
  • TROW Sell
  • DXCM Strong Buy
  • Analyst Count
  • TROW 12
  • DXCM 20
  • Target Price
  • TROW $96.67
  • DXCM $98.50
  • AVG Volume (30 Days)
  • TROW 1.4M
  • DXCM 3.7M
  • Earning Date
  • TROW 07-25-2025
  • DXCM 07-30-2025
  • Dividend Yield
  • TROW 5.07%
  • DXCM N/A
  • EPS Growth
  • TROW 4.63
  • DXCM N/A
  • EPS
  • TROW 8.81
  • DXCM 1.33
  • Revenue
  • TROW $7,107,300,000.00
  • DXCM $4,148,000,000.00
  • Revenue This Year
  • TROW $0.12
  • DXCM $16.74
  • Revenue Next Year
  • TROW $2.56
  • DXCM $15.29
  • P/E Ratio
  • TROW $11.37
  • DXCM $62.25
  • Revenue Growth
  • TROW 6.51
  • DXCM 9.11
  • 52 Week Low
  • TROW $77.85
  • DXCM $57.52
  • 52 Week High
  • TROW $125.81
  • DXCM $117.19
  • Technical
  • Relative Strength Index (RSI)
  • TROW 68.45
  • DXCM 48.21
  • Support Level
  • TROW $94.27
  • DXCM $82.75
  • Resistance Level
  • TROW $95.53
  • DXCM $87.49
  • Average True Range (ATR)
  • TROW 1.68
  • DXCM 2.64
  • MACD
  • TROW 0.66
  • DXCM -0.16
  • Stochastic Oscillator
  • TROW 94.00
  • DXCM 48.72

About TROW T. Rowe Price Group Inc.

T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load us and international stock, hybrid, bond, and money market funds. At the end of October 2024, the firm had $1.607 trillion in managed assets, composed of equity (51%), balanced (34%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a us-based asset manager, deriving less than 10% of its AUM from overseas.

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Share on Social Networks: